Literature DB >> 18270252

Retinoic acid (RA) regulates 17beta-hydroxysteroid dehydrogenase type 2 expression in endometrium: interaction of RA receptors with specificity protein (SP) 1/SP3 for estradiol metabolism.

You-Hong Cheng1, Ping Yin, Qing Xue, Bertan Yilmaz, Marcia I Dawson, Serdar E Bulun.   

Abstract

CONTEXT: The enzyme 17beta-hydroxysteroid dehydrogenase type 2 (HSD17B2) exerts a local antiestrogenic effect by metabolizing biologically active estradiol to inactive estrone in endometrial epithelial cells. Retinoic acid (RA) induces HSD17B2 expression, but the underlying mechanism is not known.
OBJECTIVE: Our objective was to elucidate the molecular mechanisms responsible for HSD17B2 expression in human endometrial cells.
METHOD: Human endometrial Ishikawa and RL95-2 cell lines were cultured in the presence or absence of RA to analyze endogenous HSD17B2 expression, transcription factor complex formation, and promoter activity.
RESULTS: RA induced HSD17B2 mRNA levels in a dose- and time-dependent manner in endometrial cells. The RA antagonist ANG11273 abolished RA-induced HSD17B2 expression. Small interfering RNA ablation of RA receptor (RAR)alpha or retinoid X receptor (RXR)alpha completely blocked RA-induced HSD17B2 gene expression. Analysis of serial deletion and site-directed mutants of the HSD17B2 promoter fused to a reporter gene indicated that RA induction requires a cis-regulatory sequence that binds the specificity protein (SP) class of transcription factors. Chromatin-immunoprecipitation-PCR and gel-shift assays showed that RARalpha/RXRalpha and SP1/SP3 interact with this HSD17B2 promoter sequence. Small interfering RNA ablation of SP1 and SP3 expression markedly decreased HSD17B2 basal expression and blocked RA-induced expression. Finally, immunoprecipitationimmunoblotting demonstrated RA-induced interactions between RARalpha/RXRalpha and SP1/SP3 in intact endometrial cells.
CONCLUSIONS: In endometrial epithelial cells, RA stimulates formation of a multimeric complex comprised of RARalpha/RXRalpha tethered to transcription factors SP1 and SP3 on the HSD17B2 promoter. Assembly of this transcriptional complex is necessary for RA induction of HSD17B2 expression and may be an important mechanism for local estradiol inactivation in the endometrium.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18270252      PMCID: PMC2386682          DOI: 10.1210/jc.2007-1536

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  36 in total

1.  Transactivation via RAR/RXR-Sp1 interaction: characterization of binding between Sp1 and GC box motif.

Authors:  J Shimada; Y Suzuki; S J Kim; P C Wang; M Matsumura; S Kojima
Journal:  Mol Endocrinol       Date:  2001-10

2.  Retinoic acid synthesis and expression of cellular retinol-binding protein and cellular retinoic acid-binding protein type II are concurrent with decidualization of rat uterine stromal cells.

Authors:  W L Zheng; E Sierra-Rivera; J Luan; K G Osteen; D E Ong
Journal:  Endocrinology       Date:  2000-02       Impact factor: 4.736

3.  Nuclear receptors modulate the interaction of Sp1 and GC-rich DNA via ternary complex formation.

Authors:  M Husmann; Y Dragneva; E Romahn; P Jehnichen
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

4.  Stromal PRs mediate induction of 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2.

Authors:  S Yang; Z Fang; B Gurates; M Tamura; J Miller; K Ferrer; S E Bulun
Journal:  Mol Endocrinol       Date:  2001-12

5.  Retinoid receptors in the human endometrium and its disorders: a possible modulator of 17 beta-hydroxysteroid dehydrogenase.

Authors:  K Ito; T Suzuki; T Moriya; H Utsunomiya; A Sugawara; R Konno; S Sato; H Sasano
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

Review 6.  Paracrine mediators of endometrial matrix metalloproteinase expression: potential targets for progestin-based treatment of endometriosis.

Authors:  Kevin G Osteen; Kaylon L Bruner-Tran; David Ong; Esther Eisenberg
Journal:  Ann N Y Acad Sci       Date:  2002-03       Impact factor: 5.691

Review 7.  Discovery and design of retinoic acid receptor and retinoid X receptor class- and subtype-selective synthetic analogs of all-trans-retinoic acid and 9-cis-retinoic acid.

Authors:  Marcia I Dawson; Xiao-kun Zhang
Journal:  Curr Med Chem       Date:  2002-03       Impact factor: 4.530

8.  Acceleration of thrombomodulin gene transcription by retinoic acid: retinoic acid receptors and Sp1 regulate the promoter activity through interactions with two different sequences in the 5'-flanking region of human gene.

Authors:  S Horie; H Ishii; F Matsumoto; M Kusano; K Kizaki; J Matsuda; M Kazama
Journal:  J Biol Chem       Date:  2000-10-17       Impact factor: 5.157

9.  Divergent effects of retinoic acids on the expression of ERalpha and 17beta-hydroxysteroid dehydrogenase type 2 in endometrial carcinoma cells (RL 95-2).

Authors:  Xiao-Hong Li; Hui Li; Zhi-Jie Xiao; Yun-Shang Piao
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

10.  Regulation of 17-beta hydroxysteroid dehydrogenase type 2 in human placental endothelial cells.

Authors:  Emily J Su; You-Hong Cheng; Robert T Chatterton; Zhi-Hong Lin; Ping Yin; Scott Reierstad; Joy Innes; Serdar E Bulun
Journal:  Biol Reprod       Date:  2007-05-30       Impact factor: 4.285

View more
  22 in total

1.  Moving Toward Integrating Gene Expression Profiling Into High-Throughput Testing: A Gene Expression Biomarker Accurately Predicts Estrogen Receptor α Modulation in a Microarray Compendium.

Authors:  Natalia Ryan; Brian Chorley; Raymond R Tice; Richard Judson; J Christopher Corton
Journal:  Toxicol Sci       Date:  2016-02-10       Impact factor: 4.849

Review 2.  Endometriosis and nuclear receptors.

Authors:  Bahar D Yilmaz; Serdar E Bulun
Journal:  Hum Reprod Update       Date:  2019-07-01       Impact factor: 15.610

3.  Fenretinide: A Potential Treatment for Endometriosis.

Authors:  Mary Ellen Pavone; Saurabh S Malpani; Matthew Dyson; J Julie Kim; Serdar E Bulun
Journal:  Reprod Sci       Date:  2016-02-25       Impact factor: 3.060

4.  Retinoic acid inhibits endometrial cancer cell growth via multiple genomic mechanisms.

Authors:  You-Hong Cheng; Hiroki Utsunomiya; Mary Ellen Pavone; Ping Yin; Serdar E Bulun
Journal:  J Mol Endocrinol       Date:  2011-03-23       Impact factor: 5.098

5.  Interactive roles of Ets-1, Sp1, and acetylated histones in the retinoic acid-dependent activation of guanylyl cyclase/atrial natriuretic peptide receptor-A gene transcription.

Authors:  Prerna Kumar; Renu Garg; Gevoni Bolden; Kailash N Pandey
Journal:  J Biol Chem       Date:  2010-09-23       Impact factor: 5.157

6.  An essential set of basic DNA response elements is required for receptor-dependent transcription of the lecithin:retinol acyltransferase (Lrat) gene.

Authors:  Reza Zolfaghari; A Catharine Ross
Journal:  Arch Biochem Biophys       Date:  2009-08-08       Impact factor: 4.013

7.  Moderate vitamin A supplementation in obese mice regulates tissue factor and cytokine production in a sex-specific manner.

Authors:  Liubov V Gushchina; Rumana Yasmeen; Ouliana Ziouzenkova
Journal:  Arch Biochem Biophys       Date:  2013-07-11       Impact factor: 4.013

8.  Endometrial and endometriotic concentrations of estrone and estradiol are determined by local metabolism rather than circulating levels.

Authors:  Kaisa Huhtinen; Reena Desai; Mia Ståhle; Anu Salminen; David J Handelsman; Antti Perheentupa; Matti Poutanen
Journal:  J Clin Endocrinol Metab       Date:  2012-09-11       Impact factor: 5.958

9.  Retinoic acid activates monoamine oxidase B promoter in human neuronal cells.

Authors:  Jason B Wu; Kevin Chen; Xiao-Ming Ou; Jean C Shih
Journal:  J Biol Chem       Date:  2009-04-28       Impact factor: 5.157

Review 10.  Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.

Authors:  J Julie Kim; Takeshi Kurita; Serdar E Bulun
Journal:  Endocr Rev       Date:  2013-01-09       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.